Novavax cut $50 million in costs, plans to slash more, CEO says
Novavax Inc cut about $50 million in costs in the first quarter of 2023 and plans to slash more, Chief Executive John Jacobs said in an interview on Wednesday.
Related Articles
COVID-19 vaccine requirements
In this TV interview, recorded 5/28/25, I discuss COVID-19’s severity in pregnancy and how recommendations for vaccination are important notwithstanding what…
Six former CDC vaccine advisory committee chairs warn: U.S. risks losing access to life-saving immunizations
“We are witnessing a dismantling of the systems that develop, license, recommend, and monitor vaccines,” write six former chairs of the CDC’s vaccine advisory committee.
Butler Senior High School chooses Distinguished Graduate
The Butler Senior High School Class of 2025 announced its choice for the 45th annual Distinguished Graduate Award — Dr. Amesh Adalja, a member of…
Vaccine advisers set to review ingredient in influenza shot
Presented by Alliance for Aging Research {beacon} Health Care Health Care PRESENTED BY The Big Story Vaccine advisers to review ingredient RFK Jr wants…
Elements in the air could help predict flu, COVID-19 surges, study finds
A new American Society for Microbiology study revealed that it could be possible to use elements in the air to predict surges in flu and…
About CBS News 24/7
CBS News 24/7 is the premier anchored streaming news service from CBS News and Stations.
Should We Be Worried About Bird Flu? Public Health Experts Say Yes
Bird flu is spreading on farms and infecting people. If the current response to the virus is a trial run in pandemic preparedness, we’ve failed…
New COVID variant causes ‘razor blade throat’
Patients and doctors say the latest COVID-19 variant spreading in the U.S. in some cases causes a sore throat so painful it has earned the…
Airborne fungal spores may help predict COVID-19 & flu surges
According to a new study, monitoring fungal spores in the outdoor air can predict surges in flu and COVID-19 infections.
With AI, researchers find increasing immune evasion in H5N1
Using artificial intelligence, researchers have identified new ways the H5N1 avian influenza virus is evolving to evade the human immune system.